(A.k.a. HMG-CoA reductase inhibitors). Convincing cases reports of ILD contrast with the lack of epidemiological evidence (PMID 17223772, 23299962). Cerivastatin was recalled/discontinued worldwide in 2001, due to an excess rate of rhabdomyolysis, a complication common to statins and other lipid-lowering agents

Last update : 16/10/2017
I - Interstitial/parenchymal lung disease
IV - Airway involvement
V - Pleural and/or pericardial involvement
VIII - Central-large-upper airway (incl. pharyngeal-nasal) involvement
IX - Neuromuscular / CNS involvement - Disordered breathing during sleep
X - Systemic/Distant conditions, syndromes and reactions
XI - Miscellaneous
XII - Cardiovascular involvement / toxicity
XV - Pathology
XVI - Imaging
XIX - Cytological, biochemical features of/in BAL, pleural fluid or FNA